Page:United States Statutes at Large Volume 107 Part 1.djvu/195

From Wikisource
Jump to navigation Jump to search
This page needs to be proofread.

PUBLIC LAW 103-43—JUNE 10, 1993 107 STAT. 169 (b) CONFORMING AMENDMENT.— Section 455 of the Public Health Service Act (42 U.S.C. 285i) is amended in the second sentence by striking "The Director" and inserting "Subject to section 456, the Director". TITLE XII—NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE SEC. 1201. RESEARCH ON MULTIPLE SCLEROSIS. Subpart 10 of part C of title IV of the Public Health Service Act (42 U.S.C. 285j et seq.) is amended by adding at the end the following section: " R ESEARCH ON MULTIPLE SCLEROSIS "SEC. 460. The Director of the Institute shall conduct and 42 USC 285j-3. support research on multiple sclerosis, especially research on effects of genetics and hormonal changes on the progress of the disease.". TITLE XIII—NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES SEC. 1301. APPLIED TOXICOLOGICAL RESEARCH AND TESTING PRO- GRAM. (a) IN GENERAL. —Subpart 12 of part C of title IV of the Public Health Service Act (42 U.S.C. 2851) is amended by adding at the 42 USC 285/. end the following section: "APPLIED TOXICOLOGICAL RESEARCH AND TESTING PROGRAM "SEC. 463A. (a) There is established within the Institute a f^^fyyi^^s'^l-f' program for conducting applied research and testing regarding toxicology, which program shall be known as the Applied Toxicological Research and Testing Program. "(b) In canning out the program established under subsection (a), the Director of the Institute shall, with respect to toxicology, carry out activities— "(1) to expand knowledge of the health effects of environmental agents; "(2) to broaden the spectrum of toxicology information that is obtained on selected chemicals; "(3) to develop and validate assays and protocols, including alternative methods that can reduce or eliminate the use of animals in acute or chronic safety testing; "(4) to establish criteria for the validation and regulatory acceptance of alternative testing and to recommend a process through which scientifically validated alternative methods can be accepted for regulatory use; "(5) to communicate the results of research to government agencies, to medical, scientific, and regulatory communities, and to the public; and "(6) to integrate related activities of the Department of Health and Human Services.".